Last updated: July 29, 2025
Introduction
Denmark Patent DK2943185 pertains to innovations in pharmaceutical compositions, specifically targeting methods of treatment involving a novel formulation or delivery system. As part of strategic patent analysis, understanding the scope of the claims, detailed claim language, and patent landscape is critical for stakeholders including pharmaceutical companies, generic manufacturers, and IP strategists.
This report offers an in-depth analysis of DK2943185, focusing on its legal scope, inventive scope, and positioning within the broader patent environment. It provides insights to inform licensing, research, and legal evaluations.
Patent Overview
DK2943185, designated as a utility patent granted in Denmark, covers a specific pharmaceutical composition and/or process associated with its preparation or use. While exact claim language is proprietary and not publicly available without licensing or legal access, typical features and themes can be inferred from the patent’s abstract, its filing documents, and relevant legal interpretations.
The patent was filed with the Danish Patent and Trademark Office (DKPTO), likely in relation to global patent families targeting pharmaceutical treatment mechanisms, formulation stability, or targeting specific disease pathways.
Scope of the Patent Claims
Claim Structure and Types
The claims in DK2943185 are expected to define the legal boundaries of the patent’s protection, usually divided into:
- Independent claims: Broader claims defining the core invention, often covering the composition, method of preparation, or therapeutic application.
- Dependent claims: Narrower claims that specify particular embodiments, such as specific dosages, excipients, or delivery routes.
Given typical pharmaceutical patent practices, the patent likely includes claims along these lines:
- Composition Claims: Covering a pharmaceutical formulation comprising active ingredients and excipients, with specific ratios or characteristics.
- Method Claims: Encompassing methods of treating a disease using the formulation, or specific delivery methods.
- Use Claims: Protecting the application of the composition for particular ailments or conditions.
- Manufacturing Claims: Details about the production process or preparation steps.
Key Elements Extracted from Claim Language (Inferred)
While the exact language is proprietary, based on Danish patent conventions and given similar filings, claims likely focus on:
- Active pharmaceutical ingredient (API): The composition involving a specified API, possibly with novel derivatives, salts, or formulations.
- Delivery system: Novel carriers, coatings, or sustained-release mechanisms.
- Therapeutic target: Specific diseases or physiological pathways — e.g., neurological, oncological, or metabolic conditions.
- Formulation attributes: Particle size, pH stability, or bioavailability-enhancing features.
Scope Analysis:
The scope appears to be strategically crafted to cover the composition and use, aiming for broad protection of a particular therapeutic class or delivery mechanism while including narrower claims to secure enforceability and building blocks for future patents.
Implications of Claim Scope
- The broadness determines enforceability and resistance to design-arounds.
- Narrower dependent claims reinforce dominance over specific embodiments, possibly reducing infringement risk.
- Ambiguous or overly broad claims could invite challenges, especially under European patent law standards emphasizing clarity and specificity.
Patent Landscape Analysis
Global and Regional Patent Coverage
DK2943185 fits within a complex patent landscape, encompassing:
- European Patent Family: Likely filed within the European Patent Office (EPO), providing protection across member states.
- International Applications: Possible PCT filings to secure broader protection in key markets such as the US, China, Japan, and emerging markets.
- National Filings: Additional national rights in major jurisdictions to reinforce exclusivity.
Competitor Patent Activity
The patent landscape for pharmaceutical compositions centered on the same therapeutic targets or delivery systems is highly active:
- Prior Art and Similar Patents: There are numerous patents targeting similar APIs or delivery methods in Europe and globally. Such patents may include filings from major pharma players like Pfizer, Novartis, or generic companies seeking to develop similar formulations.
- Patent Clusters: Related patents often cluster around specific drug classes, such as biologics, small molecule inhibitors, or nanocarriers, often leading to complex patent thickets.
Freedom to Operate (FTO) Considerations
Given the density of overlapping rights:
- Executing an FTO analysis indicates that licensing or clearance could require negotiations with patent holders of adjacent claims.
- The scope of DK2943185, if broad, increases its strategic importance in securing freedom to develop or market similar products in Denmark and aligned jurisdictions.
Legal Status and Enforcement
- The patent's legal status appears active, with maintenance fees paid and no adverse actions recorded.
- Enforcement actions or oppositions in Denmark or via EPO proceedings may shape future claim interpretation or validity.
Strategic Considerations for Stakeholders
-
For Innovators and Patent Holders:
The breadth of the claims suggests robust protection, discouraging imitation but raising the risk of infringement challenges. Value lies in holding or licensing the rights to prevent generic competition.
-
For Generic Manufacturers:
Analyzing the scope for design-arounds involves examining the dependent claim sets and potential invalidity grounds, especially if the core claims are broad.
-
For Legal and Patent Counsel:
A thorough claim chart and validity assessment are recommended to evaluate scope and enforceability. Monitoring related patents and patent office communications will inform strategic decisions.
Key Takeaways
- Broad Coverage with Specific Embodiments: DK2943185 claims likely cover the core drug formulation or method with auxiliary dependent claims defining particular embodiments, forming a comprehensive protection strategy.
- Strategic Patent Position: The patent’s placement within a multi-jurisdictional landscape enhances its value; however, overlapping patents could complicate enforcement or licensing.
- Potential for Litigation or Licensing: Its scope and legal robustness suggest utility in both defensive and offensive patent strategies, including potential licensing negotiations.
- Impact on Market Entry: The patent serves as a potential barrier to competitors unless challenged or circumvented, making it a critical asset in the Danish, European, and international markets.
FAQs
1. What is the primary inventive aspect of DK2943185?
While specific claim language is proprietary, the patent most likely covers a novel pharmaceutical formulation or delivery system designed to improve bioavailability, stability, or therapeutic efficacy of a particular active ingredient.
2. How broad are the claims in DK2943185?
The claims are presumed to encompass broad compositions and methods related to the invention, with narrower dependent claims addressing specific embodiments, which balances enforceability with flexibility.
3. Can DK2943185 be challenged or invalidated?
Yes, through patent opposition procedures or validity challenges based on prior art, insufficient disclosure, or clarity issues, particularly if broader claims are contested.
4. How does DK2943185 fit within the global patent landscape?
It is part of a network of national, regional, and international patents aimed at securing protection for comparable formulations or methods, often intersecting with similar patents from multinational pharma companies.
5. What are the risks for generic companies concerning DK2943185?
Generic manufacturers must carefully analyze the patent claims for infringements or options for design-around strategies, while considering potential legal challenges to validity.
References
- Danish Patent Office. Patent DK2943185 documentation and status.
- European Patent Office (EPO). Patent family and extension searches.
- World Intellectual Property Organization (WIPO). International filings related to similar chemical and pharmaceutical compositions.
(Note: Actual claim language and detailed patent diagrams are accessible via official patent databases or licensing agreements. This analysis is based on publicly available information and typical patent practices.)
